stockrow
Friday 6 November 2026
Export HYPR’s income statement to Excel — free account
Hyperfine, Inc.
HYPR Healthcare Medical Devices
Hyperfine, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 5.22% from fiscal 2024.
- Revenue
- +44.8%
- EPS
- +25.0%
- Free cash flow
- +13.4%
Quarter to June 2026, against a year earlier
0.72
0.03
+4.35%
Follow HYPR
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 3 | 4 | 4 |
+8 more TTM periods Free account |
| (96.97%) | (89.78%) | (79.01%) | (94.03%) | ||
| (64.40%) | (61.17%) | (62.32%) | (72.23%) | ||
ROIC |
(401.79%) | (349.87%) | (467.02%) | (518.66%) | |
Return on Tangible Assets |
(67.19%) | (71.88%) | (85.26%) | (135.86%) | |
Average Days of Receivables |
127.77 | 138.03 | 175.52 | 217.43 | |
Free Cash Flow per Share |
(0.28) | (0.29) | (0.36) | (0.41) | |
Free Cash Flow |
(27.53) | (28.66) | (29.13) | (32.23) | |
Capital Expenditures |
(0.46) | (0.95) | (1.18) | (1.13) | |
| Other line items | |||||
Cash ROIC |
(29.05%) | (32.29%) | (37.81%) | (65.90%) | |
Accounts Receivable Turnover |
2.60 | 2.35 | 1.83 | 1.38 | |
Accounts Payable Turnover |
2.98 | 2.18 | 2.41 | 2.23 | |
Inventory Turnover |
1.38 | 1.36 | 1.05 | 0.89 | |
Average Days of Payables |
110.01 | 222.12 | 217.12 | 237.32 | |
Days of Inventory on Hand |
308.36 | 308.74 | 380.01 | 373.44 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
94.23% | 106.07% | 128.67% | 176.86% | |
Selling, General and Administrative Expense of Revenue |
160.45% | 171.77% | 194.55% | 248.66% | |
Share Based Compensation of Revenue |
17.29% | 16.33% | 20.65% | 29.86% | |
Interest Coverage |
(12.60) | (11.57) | — | — | |
Operating CF/Net income |
0.78 | 0.80 | 0.79 | 0.78 | |
Depreciation/Fixed assets |
0.55 | 0.46 | 0.43 | 0.38 | |
Capex/Depreciation |
(0.37) | (0.83) | (1.09) | (1.08) | |
Revenue per Share |
0.17 | 0.16 | 0.17 | 0.13 | |
Operating CF per Share |
(0.27) | (0.28) | (0.34) | (0.39) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.03 | 0.06 | 0.09 | 0.11 |
Columns are period end dates